HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Botanicals History Of Use Should Satisfy Food GRAS Requirements - Hutt

This article was originally published in The Tan Sheet

Executive Summary

More stringent FDA regulation against functional foods containing botanical ingredients is unlikely, attorney Peter Barton Hutt (Covington & Burling) told industry reps Sept. 12.

You may also be interested in...



Nature's Way Pregnancy-6 Contains Five Herbs Restricted During Pregnancy

Five herbal ingredients in Pregnancy-6 pose potentially dangerous risks to pregnant women, FDA's Center for Food Safety & Applied Nutrition tells Nature's Way in a recent warning letter.

Functional Food Safety Challenged By CSPI, Defended By Industry

Five P&G nutritional beverages are among a group of functional food products brought to FDA's attention by the Center for Science in the Public Interest as possible adulterated or misbranded items.

Supplement seizures

FDA seizes 376 cases of Opti-Cran and other herbals valued at $500,999 from Hillestad Pharmaceuticals, the agency announces July 18. FDA had classified the items as "unapproved new drugs represented as dietary" supplements that "fail to bear adequate directions for use." The Woodruff, Wisc.-based firm received a warning letter in 1997 charging its products, including Opti-Cran, were not GRAS/E for their intended uses. FDA also seizes 927 bottles of Metabolite dietary supplement, valued at $32,400, from One World Fulfillment Distribution in Mobridge, S.D. (1see FDA Recalls & Court Actions, p. 18)

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS132902

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel